Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/43041
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Naranjo, Antonio | |
dc.contributor.author | Ojeda-Bruno, Soledad | |
dc.contributor.author | Bilbao Cantarero, Ana | |
dc.contributor.author | Quevedo Abeledo, Juan Carlos | |
dc.contributor.author | Henríquez-Hernández, Luis Alberto | |
dc.contributor.author | Rodríguez-Lozano, Carlos | |
dc.contributor.other | Naranjo Hernandez, Antonio | |
dc.contributor.other | Henriquez-Hernandez, Luis Alberto | |
dc.date.accessioned | 2018-11-21T12:13:22Z | - |
dc.date.available | 2018-11-21T12:13:22Z | - |
dc.date.issued | 2014 | |
dc.identifier.issn | 1699-258X | |
dc.identifier.uri | http://hdl.handle.net/10553/43041 | - |
dc.description.abstract | Objective: To assess the influence of the implementation of a program for secondary prevention of osteoporotic fractures on prescribing bisphosphonates and persistent short-term treatment. Patients and methods: Patients >. 50 years with fragility fracture attended in the emergency department were enrolled in an observational study. The program consisted of: 1) training of primary care physicians, 2) baseline visit: questionnaire on osteoporosis, bone densitometry and patient education, 3) patient referral to primary care, except those with multiple fractures or requiring special study or therapy, who were referred to a specialist, and 4) follow-up by checking prescriptions in electronic records, and a telephone survey. The outcome variable was the percentage of patients who, on having been prescribed bisphosphonates, still adhered to the treatment at 3 months. Results: Of the 532 patients with inclusion criteria, 202 (39%) refused to participate. Those who refused to take part had a higher mean age (P<. .01) and a higher frequency of hip fracture (P<. .01) compared with patients who did participate. A total of 330 patients were included for intervention, with a mean age of 71 years, and 254(77%) were female. An antiresorptive was being used by 45 patients (13%) at baseline. After the baseline visit 223 patients (67%) were recommended a bisphosphonate. In the follow-up at 3 months 78% of patients who had been prescribed bisphosphonate were still receiving treatment. Conclusions: We present a multidisciplinary program for secondary prevention of fractures coordinated by rheumatology in which the number of patients who were receiving bisphosphonate at 3 months increased by four times compared to baseline visit. © 2013 Elsevier España, S.L.U. | |
dc.publisher | 1699-258X | |
dc.relation.ispartof | Reumatologia Clinica | |
dc.source | Reumatologia Clinica[ISSN 1699-258X],v. 10 (5), p. 299-303 | |
dc.title | Results of a model of secondary prevention for osteoporotic fracture coordinated by rheumatology and focused on the nurse and primary care physicians | |
dc.type | info:eu-repo/semantics/Article | es |
dc.type | Article | es |
dc.identifier.doi | 10.1016/j.reuma.2013.12.007 | |
dc.identifier.scopus | 84906790010 | - |
dc.identifier.isi | 000421428100006 | |
dcterms.isPartOf | Reumatologia Clinica | |
dcterms.source | Reumatologia Clinica[ISSN 1699-258X],v. 10 (5), p. 299-303 | |
dc.contributor.authorscopusid | 7003297397 | |
dc.contributor.authorscopusid | 6602428868 | |
dc.contributor.authorscopusid | 7801311085 | |
dc.contributor.authorscopusid | 55295814500 | |
dc.contributor.authorscopusid | 15829708200 | |
dc.contributor.authorscopusid | 6603136298 | |
dc.description.lastpage | 303 | |
dc.description.firstpage | 299 | |
dc.relation.volume | 10 | |
dc.type2 | Artículo | es |
dc.identifier.wos | WOS:000421428100006 | |
dc.contributor.daisngid | 550893 | |
dc.contributor.daisngid | 4801071 | |
dc.contributor.daisngid | 8143522 | |
dc.contributor.daisngid | 7862165 | |
dc.contributor.daisngid | 465624 | |
dc.contributor.daisngid | 1048977 | |
dc.identifier.investigatorRID | E-7910-2010 | |
dc.identifier.investigatorRID | No ID | |
dc.date.coverdate | Enero 2014 | |
dc.identifier.ulpgc | Sí | es |
dc.description.esci | ESCI | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Grupo de investigaciones infecciosas, nutricionales e inflamatorias en pacientes hospitalarios / Study Group on infectious, nutritional and inflammatory diseases in hospitalized patients | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
crisitem.author.dept | GIR IUIBS: Medio Ambiente y Salud | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.orcid | 0000-0002-2013-6664 | - |
crisitem.author.orcid | 0000-0003-3237-0316 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Naranjo Hernández, Antonio | - |
crisitem.author.fullName | Henríquez Hernández, Luis Alberto | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
21
checked on Nov 17, 2024
WEB OF SCIENCETM
Citations
22
checked on Nov 17, 2024
Page view(s)
31
checked on Jul 8, 2023
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.